Envestnet Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $221M | Sell |
1,749,512
-109,500
| -6% | -$14.4M | 0.05% | 328 |
|
|
2026
Q1 | $259M | Buy |
1,859,012
+73,345
| +4% | +$10.3M | 0.07% | 257 |
|
|
2025
Q4 | $219M | Sell |
1,785,667
-42,729
| -2% | -$5.19M | 0.07% | 277 |
|
|
2025
Q3 | $203M | Sell |
1,828,396
-19,579
| -1% | -$2.23M | 0.06% | 312 |
|
|
2025
Q2 | $205M | Buy |
1,847,975
+38,568
| +2% | +$4.1M | 0.06% | 301 |
|
|
2025
Q1 | $203M | Sell |
1,809,407
-336,251
| -16% | -$34.7M | 0.07% | 285 |
|
|
2024
Q4 | $198M | Sell |
2,145,658
-382,884
| -15% | -$34.5M | 0.06% | 283 |
|
|
2024
Q3 | $212M | Buy |
2,528,542
+76,259
| +3% | +$5.82M | 0.07% | 262 |
|
|
2024
Q2 | $168M | Sell |
2,452,283
-54,929
| -2% | -$3.67M | 0.06% | 304 |
|
|
2024
Q1 | $184M | Buy |
2,507,212
+83,479
| +3% | +$6.42M | 0.07% | 272 |
|
|
2023
Q4 | $196M | Sell |
2,423,733
-169,506
| -7% | -$13.2M | 0.08% | 236 |
|
|
2023
Q3 | $194M | Buy |
2,593,239
+492,471
| +23% | +$37.9M | 0.09% | 213 |
|
|
2023
Q2 | $162M | Sell |
2,100,768
-4,542,171
| -68% | -$362M | 0.07% | 239 |
|
|
2023
Q1 | $190M | Buy |
6,642,939
+3,915,348
| +144% | +$324M | 0.09% | 197 |
|
|
2022
Q4 | $234M | Buy |
2,727,591
+129,435
| +5% | +$10.3M | 0.12% | 157 |
|
|
2022
Q3 | $160M | Buy |
2,598,156
+186,332
| +8% | +$11.7M | 0.09% | 198 |
|
|
2022
Q2 | $149M | Buy |
2,411,824
+222,391
| +10% | +$13.8M | 0.08% | 214 |
|
|
2022
Q1 | $130M | Buy |
2,189,433
+160,481
| +8% | +$10.3M | 0.07% | 254 |
|
|
2021
Q4 | $147M | Buy |
2,028,952
+73,714
| +4% | +$5.08M | 0.07% | 235 |
|
|
2021
Q3 | $137M | Sell |
1,955,238
-27,069
| -1% | -$1.9M | 0.08% | 222 |
|
|
2021
Q2 | $137M | Buy |
1,982,307
+252,245
| +15% | +$16.8M | 0.08% | 221 |
|
|
2021
Q1 | $112M | Buy |
1,730,062
+380,145
| +28% | +$24.5M | 0.07% | 223 |
|
|
2020
Q4 | $78.6M | Buy |
1,349,917
+47,061
| +4% | +$2.84M | 0.06% | 247 |
|
|
2020
Q3 | $82.3M | Buy |
1,302,856
+258,483
| +25% | +$17.9M | 0.07% | 205 |
|
|
2020
Q2 | $80.4M | Sell |
1,044,373
-254,686
| -20% | -$19.5M | 0.08% | 204 |
|
|
2020
Q1 | $97.1M | Buy |
1,299,059
+12,369
| +1% | +$855K | 0.12% | 145 |
|
|
2019
Q4 | $83.6M | Buy |
1,286,690
+46,899
| +4% | +$3.05M | 0.09% | 174 |
|
|
2019
Q3 | $78.6M | Buy |
1,239,791
+468,935
| +61% | +$30.7M | 0.09% | 176 |
|
|
2019
Q2 | $52.1M | Sell |
770,856
-31,327
| -4% | -$2.06M | 0.07% | 223 |
|
|
2019
Q1 | $52.1M | Buy |
802,183
+80,890
| +11% | +$5.38M | 0.07% | 202 |
|
|
2018
Q4 | $45.1M | Buy |
721,293
+510,704
| +243% | +$35.7M | 0.07% | 198 |
|
|
2018
Q3 | $16.3M | Sell |
210,589
-375,228
| -64% | -$28.3M | 0.03% | 216 |
|
|
2018
Q2 | $41.5M | Buy |
585,817
+500,802
| +589% | +$35.4M | 0.09% | 108 |
|
|
2018
Q1 | $6.35M | Sell |
85,015
-533,087
| -86% | -$42.4M | 0.02% | 336 |
|
|
2017
Q4 | $44.3M | Sell |
618,102
-3,308
| -0.5% | -$251K | 0.1% | 109 |
|
|
2017
Q3 | $50.4M | Buy |
621,410
+10,759
| +2% | +$823K | 0.12% | 96 |
|
|
2017
Q2 | $43.2M | Buy |
610,651
+82,979
| +16% | +$5.52M | 0.12% | 107 |
|
|
2017
Q1 | $35.8M | Buy |
527,672
+151,387
| +40% | +$10.6M | 0.11% | 119 |
|
|
2016
Q4 | $26.9M | Sell |
376,285
-25,204
| -6% | -$1.87M | 0.1% | 149 |
|
|
2016
Q3 | $31.8M | Sell |
401,489
-58,583
| -13% | -$4.76M | 0.12% | 131 |
|
|
2016
Q2 | $38.4M | Sell |
460,072
-17,118
| -4% | -$1.52M | 0.15% | 114 |
|
|
2016
Q1 | $43.8M | Sell |
477,190
-89,575
| -16% | -$8.08M | 0.19% | 89 |
|
|
2015
Q4 | $57.4M | Buy |
566,765
+12,421
| +2% | +$1.29M | 0.26% | 62 |
|
|
2015
Q3 | $54.4M | Buy |
554,344
+83,789
| +18% | +$9.31M | 0.27% | 61 |
|
|
2015
Q2 | $55.1M | Buy |
470,555
+1,488
| +0.3% | +$163K | 0.26% | 69 |
|
|
2015
Q1 | $46M | Buy |
469,067
+422,763
| +913% | +$42.9M | 0.24% | 89 |
|
|
2014
Q4 | $4.37M | Sell |
46,304
-8,015
| -15% | -$829K | 0.04% | 239 |
|
|
2014
Q3 | $5.78M | Buy |
54,319
+18,568
| +52% | +$1.82M | 0.06% | 228 |
|
|
2014
Q2 | $2.96M | Buy |
35,751
+9,668
| +37% | +$753K | 0.03% | 299 |
|
|
2014
Q1 | $1.85M | Sell |
26,083
-11,860
| -31% | -$930K | 0.02% | 332 |
|
|
2013
Q4 | $2.85M | Sell |
37,943
-1,512
| -4% | -$105K | 0.03% | 262 |
|
|
2013
Q3 | $2.48M | Sell |
39,455
-2,712
| -6% | -$162K | 0.03% | 265 |
|
|
2013
Q2 | $2.16M | Buy |
+42,167
| New | +$2.2M | 0.03% | 267 |
|
Other funds holding GILD
Envestnet Asset Management's GILD Position: Q2 2026 in Review
Envestnet Asset Management reduced its Gilead Sciences (GILD) stake by 5.9% in Q2 2026, selling an estimated $14.4M and leaving 1,749,512 shares worth $221M. The position accounts for 0.05% of the portfolio, ranked #328.
Envestnet Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $259M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Envestnet Asset Management held 1,749,512 shares of Gilead Sciences worth $221M as of Q2 2026.
- Envestnet Asset Management sold 109,500 Gilead Sciences shares in Q2 2026, an estimated $14.4M.
- Gilead Sciences made up 0.05% of Envestnet Asset Management's portfolio in Q2 2026, its #328 holding.
- Envestnet Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Envestnet Asset Management's Gilead Sciences position peaked at $259M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.